XML 38 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
NET INCOME PER COMMON SHARE
9 Months Ended
Sep. 30, 2017
Earnings Per Share [Abstract]  
NET INCOME PER COMMON SHARE

17.

NET INCOME PER COMMON SHARE:

The Company computes earnings per share in accordance with ASC Topic 260, Earnings per Share ("ASC 260"), which requires earnings per share for each class of stock to be calculated using the two-class method. The two-class method is an allocation of income between the holders of common stock and the Company's participating security holders. Under the two-class method, income for the reporting period is allocated between common shareholders and other security holders based on their respective participation rights in undistributed income. Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and, therefore, are included in computing earnings per share pursuant to the two-class method.

Basic net income per common share is computed by dividing net income allocated to common shareholders by the weighted-average number of shares of common stock outstanding for the period excluding unvested restricted stock units and performance units. Net income allocated to the holders of the Company's unvested restricted stock awards is calculated based on the shareholder’s proportionate share of weighted average shares of common stock outstanding on an if-converted basis.

For purposes of determining diluted net income per common share, basic net income per share is further adjusted to include the effect of potential dilutive common shares outstanding, including stock options, restricted stock units and performance units, and the impact of shares to be issued under the ESPP.

The following table is a reconciliation of net income and the shares used in calculating basic and diluted net income per common share for the three and nine months ended September 30, 2017 and 2016 (in thousands, except share and per share data):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

13,520

 

 

$

(1,500

)

 

$

71,072

 

 

$

22,251

 

Adjustment for Basic EPS:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earning allocated to unvested shareholders

 

 

(199

)

 

 

 

 

 

(1,149

)

 

 

 

Adjusted net income

 

$

13,321

 

 

$

(1,500

)

 

$

69,923

 

 

$

22,251

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – Basic

 

 

46,801,051

 

 

 

46,947,621

 

 

 

46,716,726

 

 

 

46,889,913

 

Effect of dilutive shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock equivalents arising from stock

   options and ESPP

 

 

1,130

 

 

 

 

 

 

2,438

 

 

 

5,948

 

Restricted stock awards and units and performance

   units

 

 

69,539

 

 

 

 

 

 

74,265

 

 

 

119,401

 

Weighted average common shares

   outstanding – Diluted

 

 

46,871,720

 

 

 

46,947,621

 

 

 

46,793,429

 

 

 

47,015,262

 

Net income per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.28

 

 

$

(0.03

)

 

$

1.50

 

 

$

0.47

 

Diluted

 

$

0.28

 

 

$

(0.03

)

 

$

1.49

 

 

$

0.47

 

For the three months ended September 30, 2017 and 2016, there were zero and 125,869 unvested restricted stock awards, restricted stock units, performance unit awards and stock options excluded from the calculation of diluted EPS as their impact would have been antidilutive. For the nine months ended September 30, 2017 and 2016, there were zero unvested restricted stock awards, restricted stock units, performance unit awards and stock options excluded from the calculation of diluted EPS as their impact would have been antidilutive. The impact of shares to be issued under the ESPP, which was not significant, was excluded from the calculation of diluted EPS as their impact would have been antidilutive.